# E133: Obinutuzumab for SLE (ALLEGORY)

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e133-obinutuzumab-for-sle-allegory
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e133-obinutuzumab-for-sle-allegory.md
Podcast: [The Evidence Based Rheumatology Podcast](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175)
Published: 2026-03-19T19:32:38+00:00
Episode link: https://msputman.podbean.com/e/e133-obinutuzumab-for-sle-allegory/
Audio file: https://mcdn.podbean.com/mf/web/vr83zyy725hqk2xp/e133.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e133-obinutuzumab-for-sle-allegory
Duration seconds: 921

## Resource

Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece! Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2516150 Landing Page: https://ebrheum.com/ Substack: https://autoimmunedevreport.substack.com/

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e133-obinutuzumab-for-sle-allegory/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e133-obinutuzumab-for-sle-allegory.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.